Dr. Gulshan Dangol, MD

Dr. Dangol practices at HSHS St. John's Hospital in Springfield, Illinois, part of Hospital Sisters of St. Francis.

Dr. Dangol's NPI, 1134504129, was assigned on July 20, 2015. Dr. Dangol holds Oklahoma license 34500.

Dr. Dangol's primary practice is HSHS St. John's Hospital, at 800 E Carpenter St, Springfield, IL 62769 in Sangamon County. The practice phone is (217) 544-6464.

Dr. Dangol's primary practice is HSHS St. John's Hospital in Springfield, Illinois, part of Hospital Sisters of St. Francis. Dr. Dangol is also affiliated with Hillsboro Health. The medical group on file is Vituity (formerly CEP America). Dmand AI also links Dr. Dangol to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dangol practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Dangol's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Dangol's licenses on file in 2 states: Oklahoma and Illinois.

CMS data shows 1,134 Medicare services from Dr. Dangol across 6 procedure codes in 2024, for 393 Medicare patients. Medicare paid $81,148 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 393 Medicare patients who saw Dr. Dangol in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dangol's median patient age at 68, with 52% women.

In 2024, Dr. Dangol wrote 551 Medicare Part D claims for 194 patients. 83% of them were for generic drugs. CMS names the drug for 254 of them, across 13 drugs with 11 or more claims each, at $17,481 in total drug cost. In 2023, CMS named 284 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dangol for performance year 2024, reported as part of a group. Dr. Dangol accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Dr. Dangol from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abbott Laboratories paid the most, $134.